Literature DB >> 6222095

Methylene blue. A possible treatment for manic depressive psychosis.

S L Narsapur, G J Naylor.   

Abstract

Methylene blue was given to patients who had failed to respond to standard therapies. Of the 19 manic depressives who received oral methylene blue, 14 were judged to show definite improvement, 3 patients in whom the diagnosis was uncertain showed no beneficial response.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6222095     DOI： 10.1016/0165-0327(83)90008-3

Source DB:  PubMed          Journal:  J Affect Disord        ISSN： 0165-0327            Impact factor:   4.839


  9 in total

1.  Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.

Authors:  Takashi Mori; Naoki Koyama; Tatsuya Segawa; Masahiro Maeda; Nobuhiro Maruyama; Noriaki Kinoshita; Huayan Hou; Jun Tan; Terrence Town
Journal:  J Biol Chem       Date:  2014-08-25       Impact factor: 5.157

2.  Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo.

Authors:  G Wegener; V Volke; R Rosenberg
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

3.  Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

Authors:  Demian Obregon; Ellisa Carla Parker-Athill; Jun Tan; Tanya Murphy
Journal:  Neuropsychiatry (London)       Date:  2012-08

4.  Methylene Blue in the Treatment of Neuropsychiatric Disorders.

Authors:  Martin Alda
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 5.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

Review 6.  Methylene blue and its analogues as antidepressant compounds.

Authors:  Anzelle Delport; Brian H Harvey; Anél Petzer; Jacobus P Petzer
Journal:  Metab Brain Dis       Date:  2017-07-31       Impact factor: 3.584

7.  Anti-tumoral and anti-inflammatory effects of biological stains.

Authors:  F Culo; D Sabolović; L Somogyi; M Marusić; N Berbiguier; L Galey
Journal:  Agents Actions       Date:  1991-11

Review 8.  Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation.

Authors:  Luodan Yang; Hannah Youngblood; Chongyun Wu; Quanguang Zhang
Journal:  Transl Neurodegener       Date:  2020-06-01       Impact factor: 8.014

Review 9.  Nitric Oxide Synthase Inhibitors as Antidepressants.

Authors:  Gregers Wegener; Vallo Volke
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.